Indrayani Biotech Limited (BOM:526445)
17.64
-0.36 (-2.00%)
At close: May 6, 2025
Indrayani Biotech Revenue
Indrayani Biotech had revenue of 173.18M INR in the quarter ending December 31, 2024, a decrease of -57.18%. This brings the company's revenue in the last twelve months to 1.24B, down -30.31% year-over-year. In the fiscal year ending March 31, 2024, Indrayani Biotech had annual revenue of 1.66B with 2.02% growth.
Revenue (ttm)
1.24B
Revenue Growth
-30.31%
P/S Ratio
0.61
Revenue / Employee
1.12M
Employees
1,112
Market Cap
756.81M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 1.66B | 32.96M | 2.02% |
Mar 31, 2023 | 1.63B | 1.01B | 164.57% |
Mar 31, 2022 | 615.82M | 403.91M | 190.60% |
Mar 31, 2021 | 211.91M | -287.06M | -57.53% |
Mar 31, 2020 | 498.97M | - | - |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2012 | Pro | Pro | Pro |
Mar 31, 2011 | Pro | Pro | Pro |
Mar 31, 2010 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,646.93B |
HDFC Bank | 2,728.47B |
Tata Consultancy Services | 2,553.24B |
Bharti Airtel | 1,627.08B |
ICICI Bank | 2,006.54B |
State Bank of India | 3,429.39B |
Infosys | 1,647.16B |
Hindustan Unilever | 631.21B |